There is "insufficient" evidence available to support the introduction a Meningitis B immunisation, Government-appointed experts have said.
The Joint Committee on Vaccination and Immunisation (JCVI) said the efficacy of the Bexsero vaccine "has not been established" and it is "high unlikely" to be cost-effective.
The vaccine was licensed by the European Medicines Agency at the start of the year.
More top news
Energy companies are under fire this lunchtime after official figures indicate they are increasing their pre-tax profit margins.
The Deputy Prime Minister said disabled children's access to education should not be means-tested, even if the parent's do earn millions.
Andy Murray is through to Australian Open final after beating Tomas Berdych three sets to one in a thrilling semi-final